دورية أكاديمية
أعرض في EDS

Level and Timing of Implanon Discontinuation and Associated Factors among Women Who Used Implanon in Andabet District, Public Health Facilities, North-West Ethiopia.

التفاصيل البيبلوغرافية
العنوان: Level and Timing of Implanon Discontinuation and Associated Factors among Women Who Used Implanon in Andabet District, Public Health Facilities, North-West Ethiopia.
المؤلفون: Dagnew GW; Department of Reproductive Health and Population Studies, School of Public Health, College of and Health Science, Bahir Dar University, Bahir Dar, Ethiopia., Gelaw YM; Department of Health Service Management, School of Public Health, College of and Health Science, Bahir Dar University, Bahir Dar, Ethiopia., Asresie MB; Department of Reproductive Health and Population Studies, School of Public Health, College of and Health Science, Bahir Dar University, Bahir Dar, Ethiopia., Anteneh ZA; Department of Biostatistics and Epidemiology, School of Public Health, College of and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
المصدر: BioMed research international [Biomed Res Int] 2021 Aug 06; Vol. 2021, pp. 6647660. Date of Electronic Publication: 2021 Aug 06 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Hindawi Pub. Co.
مواضيع طبية MeSH: Contraceptive Agents, Female/*administration & dosage , Desogestrel/*administration & dosage , Medication Adherence/*psychology , Patient Satisfaction/*statistics & numerical data, Adolescent ; Adult ; Cross-Sectional Studies ; Ethiopia ; Female ; Humans ; Interviews as Topic ; Logistic Models ; Medication Adherence/statistics & numerical data ; Middle Aged ; Sample Size ; Time Factors ; Women's Health Services ; Young Adult
مستخلص: Background: Implanon discontinuation is unacceptably high in developing countries, including Ethiopia. Furthermore, there is an observed problem of high unintended pregnancy after method discontinuation that strides to program failure. Therefore, the purpose of this study was to assess the level and determinants of Implanon discontinuation among women who used Implanon in Andabet district, public health facilities, North-West Ethiopia, 2017.
Methods: Facility-based cross-sectional study design was employed among 537 women from Feb. 03 to April 28, 2017. Study participants were selected using a systematic random sampling technique. A face-to-face interview was employed to collect data. Epi-Info version 7 was used for data entry and SPSS version 20 for analysis. Both descriptive and analytical statistical analysis was computed. On multivariable binary logistic regression, a p value of less than 0.05 was used to declare statistical significance.
Results: About 37% of Implanon users have discontinued the method before the intended time. About 86% of them discontinued Implanon before two years of insertion. Women who had no live child (AOR = 2.17, 95% CI: 1.25-3.77), women who did not receive preinsertion counseling (AOR = 1.85, 95% CI: 1.15-2.97), women who developed Implanon-related side effect (AOR = 5.17, 95% CI: 3.18-8.40), and women who did not satisfy by the service provided (AOR = 5.40, 95% CI: 3.04-9.57) had higher odds of Implanon discontinuation. On the other hand, women who received appointment follow-up (AOR = 0.23, 95% CI: 0.13-0.41) had lower odds of Implanon discontinuation.
Conclusions: The level of Implanon discontinuation before its intended time was high in the district. Hence, strengthening preinsertion counseling and appointment follow-up as well as improving the clients' level of service satisfaction could increase Implanon's continuation.
Competing Interests: We do not have any competing interests.
(Copyright © 2021 Gizachew Worku Dagnew et al.)
References: BMC Womens Health. 2020 Oct 23;20(1):239. (PMID: 33097056)
Med J Aust. 2013 Sep 2;199(5):317-8. (PMID: 23992177)
PLoS One. 2011;6(7):e22515. (PMID: 21799882)
Int J Reprod Med. 2017;2017:2861207. (PMID: 29234726)
Contraception. 2011 May;83(5):426-30. (PMID: 21477684)
Obstet Gynecol. 2011 May;117(5):1105-1113. (PMID: 21508749)
J Obstet Gynaecol India. 2011 Aug;61(4):422-5. (PMID: 22851825)
Stud Fam Plann. 2019 Mar;50(1):3-24. (PMID: 30791104)
Int Perspect Sex Reprod Health. 2011 Jun;37(2):58-66. (PMID: 21757420)
Fertil Steril. 2009 May;91(5):1646-53. (PMID: 18423453)
Int J Reprod Med. 2018 Jan 21;2018:3597487. (PMID: 29796392)
Reprod Health. 2014 Apr 04;11:27. (PMID: 24708827)
Int J Womens Health. 2014 Feb 19;6:221-34. (PMID: 24570597)
Glob Health Sci Pract. 2013 Mar 21;1(1):11-7. (PMID: 25276512)
Contracept Reprod Med. 2020 Oct 23;5:29. (PMID: 33110625)
Int Fam Plan Perspect. 2003 Mar;29(1):6-13. (PMID: 12709307)
Afr J Reprod Health. 2014 Mar;18(1):84-92. (PMID: 24796172)
Eur J Contracept Reprod Health Care. 2014 Feb;19(1):15-21. (PMID: 24329119)
Obstet Gynecol. 2012 Dec;120(6):1298-305. (PMID: 23168753)
Int Fam Plan Perspect. 2005 Mar;31(1):15-23. (PMID: 15888405)
Hum Reprod Update. 2003 Jan-Feb;9(1):49-59. (PMID: 12638781)
Int J Gynaecol Obstet. 2013 Nov;123 Suppl 1:e29-32. (PMID: 24035007)
Lancet. 2013 May 11;381(9878):1642-52. (PMID: 23489750)
Contraception. 2013 Aug;88(2):250-6. (PMID: 23177265)
Contraception. 2015 Apr;91(4):301-7. (PMID: 25553872)
Rev Panam Salud Publica. 2008 Jun;23(6):410-7. (PMID: 18644209)
Contraception. 2012 Nov;86(5):511-7. (PMID: 22633247)
BMC Int Health Hum Rights. 2014 Dec 02;14:33. (PMID: 25439300)
Ann Afr Med. 2012 Jan-Mar;11(1):27-31. (PMID: 22199044)
المشرفين على المادة: 0 (Contraceptive Agents, Female)
304GTH6RNH (etonogestrel)
81K9V7M3A3 (Desogestrel)
تواريخ الأحداث: Date Created: 20210816 Date Completed: 20210928 Latest Revision: 20220425
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8363448
DOI: 10.1155/2021/6647660
PMID: 34395623
قاعدة البيانات: MEDLINE
الوصف
تدمد:2314-6141
DOI:10.1155/2021/6647660